Consumer Marketing Manager at Eli Lilly and Company

Toronto, Ontario, Canada

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor's degree in Marketing, Business Administration, or related field
3+ years of full-time experience in consumer marketing (or brand management/digital marketing), preferably from consumer packaged goods, tech, or financial (B2C non-pharma) industry
Proven experience in consumer marketing within a highly regulated environment, including managing external agencies for media buying and creative development
Demonstrated leadership in leveraging consumer insights to execute PESO campaigns (paid, earned, shared, owned) with excellence
Ability to navigate ambiguity, lead without authority, and take initiative to drive change (preferably with experience in a large matrixed organization)
Strong analytical skills in data-driven marketing decision-making, performance measurement, and campaign optimization
Excellent communication, project management, and leadership skills, with experience collaborating with cross-functional partners such as communications, digital, legal, global, etc

Responsibilities

Own end-to-end patient experience and develop consumer-centric marketing plans in partnership with brand teams and global colleagues, aligning with strategic objectives and growth targets
Champion a consumer-first mindset to evolve beyond traditional pharma, lead priority consumer initiatives, and drive change across the organization by building new consumer capabilities
Manage agency partners to develop breakthrough media plans, campaign execution, and creative assets, while operating within a highly regulated environment
Initiate and leverage market research and consumer insights to identify growth opportunities and provide consumer perspective to cross-functional teams
Drive digital strategy and execution (website, social, etc), ensuring connectivity across PESO touchpoints (paid, earned, shared, owned)
Measure performance with analytical rigour and assess effectiveness of consumer marketing campaigns
Influence and collaborate closely with cross functional partners, including brand, patient support program, digital, communications, medical affairs, regulatory, legal, and global teams
Stay abreast of industry trends, innovations, and regulatory changes to adapt marketing strategies

Skills

Consumer Marketing

DTC Marketing

Digital Strategy

Media Planning

Market Research

Consumer Insights

Data Analytics

Campaign Execution

PESO

Agency Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free